FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
latest-news-card-1
Human Drugs

CDER Head Targets Surrogate Endpoints, Lupus Drug

In an unprecedented LinkedIn post, CDER director George Tidmarsh questions the use of surrogate endpoints and publicly attacks Aurinia Pharmas Lupus d...

latest-news-card-1
Human Drugs

Quantitative Medicine CoE Progress Update

The CDER Quantitative Medicine Center of Excellence issues a report on goals and accomplishments in the first 16 months of its existence.

FDA General

Sharp Reductions in FDA Operations Under Shutdown: HHS

An HHS contingency plan says FDA would experience sharp reductions in operations if Congress fails to reach a deal to fund the government.

latest-news-card-1
Medical Devices

FDA Approves New Zoll Monitor/Defibrillator

FDA approves a Zoll Medical PMA for Zenix, the companys newest monitor/defibrillator, which the company says is designed to streamline emergency and h...

latest-news-card-1
Human Drugs

OND Custom Medical Queries Are Useful: Article

FDA researchers say the OND Custom Medical Queries developed to improve the identification and analysis of new drug safety signals have improved FDAs ...

latest-news-card-1
Human Drugs

New Guidance on Adaptive Clinical Trial Designs

FDA posts an International Council for Harmonization draft guideline entitled E20 Adaptive Designs for Clinical Trials that provides recommendations o...

latest-news-card-1
Medical Devices

CDRH Expands Recall of BD Alaris Pump Infusion Sets

FDA issues an updated alert about an ongoing Class 1 recall of certain BD Alaris Pump Module infusion sets due to device performance issues.

FDA General

FDA Protected From Firings During Shutdown: Makary

FDA commissioner Marty Makary tells agency employees that they are protected from planned mass workforce firings if a government shutdown goes into ef...

latest-news-card-1
Human Drugs

Draft Guide on Disseminated Valley Fever Treatments

FDA posts a draft guidance to help drugmakers design clinical trials for treatments targeting disseminated coccidioidomycosis, also known as Valley Fe...

latest-news-card-1
Human Drugs

Larimar Reports Positive Data for Nomlabofusp

Larimar Therapeutics reports encouraging long-term data from its open-label study of nomlabofusp, an investigational therapy for Friedreichs ataxia.